Human mammary cancer progression model recapitulates methylation events associated with breast premalignancy

Breast Cancer Research

Volumn 11, Issue 6, 2009, Pages

  Dumont, Nancy ^a   Crawford, Yongping G ^a,d   Sigaroudinia, Mahvash ^a   Nagrani, Shefali S ^a   Wilson, Matthew B ^a,e   Buehring, Gertrude C ^b   Turashvili, Gulisa ^c   Aparicio, Samuel ^c   Gauthier, Mona L ^a,f   Fordyce, Colleen A ^a   McDermott, Kimberly M ^a,g   Tlsty, Thea D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^d GENENTECH INC   (United States)

^e NATIONAL SCIENCE FOUNDATION   (United States)

^f UNIVERSITY OF TORONTO   (Canada)

^g UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYCLIN DEPENDENT KINASE INHIBITOR 2A; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; SECRETED FRIZZLED RELATED PROTEIN 1; TELOMERASE; MEMBRANE PROTEIN; RASSF1 PROTEIN, HUMAN; SFRP1 PROTEIN, HUMAN; SIGNAL PEPTIDE; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE ARREST; CELL IMMORTALIZATION; CELL PROLIFERATION; CHROMOSOME ABERRATION; DNA METHYLATION; ENZYME ACTIVITY; EPIGENETICS; FEMALE; FIBROBLAST; GENE LOCUS; HUMAN; HUMAN CELL; METHYLATION; MICROENVIRONMENT; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRECANCER; PROTEIN EXPRESSION; STRESS; UPREGULATION; ANIMAL; BREAST TUMOR; CELL ADHESION; CELL GROWTH; DISEASE COURSE; GENETICS; METABOLISM; MOUSE MUTANT; ONCOGENE RAS; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

ANIMALS; BREAST NEOPLASMS; CELL ADHESION; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; DISEASE PROGRESSION; DNA METHYLATION; FEMALE; GENES, P16; GENES, RAS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICE; MICE, SCID; PRECANCEROUS CONDITIONS; TELOMERASE; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 77954609358     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2457     Document Type: Article

References (45)

1. Theillet C, Lidereau R, Escot C, Hutzell P, Brunet M, Gest J, Schlom J, Callahan R. Loss of a c-H-ras-1 allele and aggressive human primary breast carcinomas. Cancer Res 1986, 46:4776-4781.
2. Spandidos DA, Agnantis NJ. Human malignant tumours of the breast, as compared to their respective normal tissue, have elevated expression of the Harvey ras oncogene. Anticancer Res 1984, 4:269-272.
3. Hand PH, Vilasi V, Thor A, Ohuchi N, Schlom J. Quantitation of Harvey ras p21 enhanced expression in human breast and colon carcinomas. J Natl Cancer Inst 1987, 79:59-65.
4. De Biasi F, Del Sal G, Hand PH. Evidence of enhancement of the ras oncogene protein product (p21) in a spectrum of human tumors. Int J Cancer 1989, 43:431-435. 10.1002/ijc.2910430315, 2784420.
5. Ohuchi N, Thor A, Page DL, Hand PH, Halter SA, Schlom J. Expression of the 21,000 molecular weight ras protein in a spectrum of benign and malignant human mammary tissues. Cancer Res 1986, 46:2511-2519.
6. Cheng X. Silent assassin: oncogenic ras directs epigenetic inactivation of target genes. Sci Signal 2008, 1:pe14. 10.1126/stke.113pe14, 18385037.
7. Veeck J, Niederacher D, An H, Klopocki E, Wiesmann F, Betz B, Galm O, Camara O, Durst M, Kristiansen G, Huszka C, Knüchel R, Dahl E. Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis. Oncogene 2006, 25:3479-3488. 10.1038/sj.onc.1209386, 16449975.
8. Munot K, Bell SM, Lane S, Horgan K, Hanby AM, Speirs V. Pattern of expression of genes linked to epigenetic silencing in human breast cancer. Hum Pathol 2006, 37:989-999. 10.1016/j.humpath.2006.04.013, 16867861.
9. Ordway JM, Budiman MA, Korshunova Y, Maloney RK, Bedell JA, Citek RW, Bacher B, Peterson S, Rohlfing T, Hall J, Brown R, Lakey N, Doerge RW, Martienssen RA, Leon J, McPherson JD, Jeddeloh JA. Identification of novel high-frequency DNA methylation changes in breast cancer. PLoS ONE 2007, 2:e1314. 10.1371/journal.pone.0001314, 2117343, 18091988.
10. Veeck J, Geisler C, Noetzel E, Alkaya S, Hartmann A, Knuchel R, Dahl E. Epigenetic inactivation of the Secreted frizzled-related protein-5 (SFRP5) gene in human breast cancer is associated with unfavorable prognosis. Carcinogenesis 2008, 29:991-998. 10.1093/carcin/bgn076, 18356147.
11. Kobatake T, Yano M, Toyooka S, Tsukuda K, Dote H, Kikuchi T, Toyota M, Ouchida M, Aoe M, Date H, Pass HI, Doihara H, Shimizu N. Aberrant methylation of p57KIP2 gene in lung and breast cancers and malignant mesotheliomas. Oncol Rep 2004, 12:1087-1092.
12. Fackler MJ, McVeigh M, Evron E, Garrett E, Mehrotra J, Polyak K, Sukumar S, Argani P. DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma. Int J Cancer 2003, 107:970-975. 10.1002/ijc.11508, 14601057.
13. Tommasi S, Karm DL, Wu X, Yen Y, Pfeifer GP. Methylation of homeobox genes is a frequent and early epigenetic event in breast cancer. Breast Cancer Res 2009, 11:R14. 10.1186/bcr2233, 2687719, 19250546.
14. Crawford YG, Gauthier ML, Joubel A, Mantei K, Kozakiewicz K, Afshari CA, Tlsty TD. Histologically normal human mammary epithelia with silenced p16(INK4a) overexpress COX-2, promoting a premalignant program. Cancer Cell 2004, 5:263-273. 10.1016/S1535-6108(04)00023-6, 15050918.
15. Romanov SR, Kozakiewicz BK, Holst CR, Stampfer MR, Haupt LM, Tlsty TD. Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature 2001, 409:633-637. 10.1038/35054579, 11214324.
16. Reynolds PA, Sigaroudinia M, Zardo G, Wilson MB, Benton GM, Miller CJ, Hong C, Fridlyand J, Costello JF, Tlsty TD. Tumor suppressor p16INK4A regulates polycomb-mediated DNA hypermethylation in human mammary epithelial cells. J Biol Chem 2006, 281:24790-24802. 10.1074/jbc.M604175200, 16766534.
17. McDermott KM, Zhang J, Holst CR, Kozakiewicz BK, Singla V, Tlsty TD. p16(INK4a) prevents centrosome dysfunction and genomic instability in primary cells. PLoS Biol 2006, 4:e51. 10.1371/journal.pbio.0040051, 1361797, 16464125.
18. Holst CR, Nuovo GJ, Esteller M, Chew K, Baylin SB, Herman JG, Tlsty TD. Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia. Cancer Res 2003, 63:1596-1601.
19. Gauthier ML, Pickering CR, Miller CJ, Fordyce CA, Chew KL, Berman HK, Tlsty TD. p38 regulates cyclooxygenase-2 in human mammary epithelial cells and is activated in premalignant tissue. Cancer Res 2005, 65:1792-1799. 10.1158/0008-5472.CAN-04-3507, 15753376.
20. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997, 88:593-602. 10.1016/S0092-8674(00)81902-9, 9054499.
21. Hammond SL, Ham RG, Stampfer MR. Serum-free growth of human mammary epithelial cells: rapid clonal growth in defined medium and extended serial passage with pituitary extract. Proc Natl Acad Sci USA 1984, 81:5435-5439. 10.1073/pnas.81.17.5435, 391719, 6591199.
22. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996, 93:9821-9826. 10.1073/pnas.93.18.9821, 38513, 8790415.
23. Gao Y, Guan M, Su B, Liu W, Xu M, Lu Y. Hypermethylation of the RASSF1A gene in gliomas. Clin Chim Acta 2004, 349:173-179. 10.1016/j.cccn.2004.07.006, 15469871.
24. Suzuki H, Toyota M, Caraway H, Gabrielson E, Ohmura T, Fujikane T, Nishikawa N, Sogabe Y, Nojima M, Sonoda T, Mori M, Hirata K, Imai K, Shinomura Y, Baylin SB, Tokino T. Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer. Br J Cancer 2008, 98:1147-1156. 10.1038/sj.bjc.6604259, 2275475, 18283316.
25. Petko Z, Ghiassi M, Shuber A, Gorham J, Smalley W, Washington MK, Schultenover S, Gautam S, Markowitz SD, Grady WM. Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon polyps and in fecal DNA from patients with colorectal polyps. Clin Cancer Res 2005, 11:1203-1209.
26. Guerrero D, Guarch R, Ojer A, Casas JM, Ropero S, Mancha A, Pesce C, Lloveras B, Garcia-Bragado F, Puras A. Hypermethylation of the thrombospondin-1 gene is associated with poor prognosis in penile squamous cell carcinoma. BJU Int 2008, 102:747-755. 10.1111/j.1464-410X.2008.07603.x, 18336597.
27. Dimri G, Band H, Band V. Mammary epithelial cell transformation: insights from cell culture and mouse models. Breast Cancer Res 2005, 7:171-179. 10.1186/bcr1275, 1175079, 15987472.
28. Elenbaas B, Spirio L, Koerner F, Fleming MD, Zimonjic DB, Donaher JL, Popescu NC, Hahn WC, Weinberg RA. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev 2001, 15:50-65. 10.1101/gad.828901, 312602, 11156605.
29. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL, Weinberg RA. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005, 121:335-348. 10.1016/j.cell.2005.02.034, 15882617.
30. Chang HY, Sneddon JB, Alizadeh AA, Sood R, West RB, Montgomery K, Chi JT, Rijn M, Botstein D, Brown PO. Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biol 2004, 2:E7. 10.1371/journal.pbio.0020007, 314300, 14737219.
31. Rangarajan A, Hong SJ, Gifford A, Weinberg RA. Species- and cell type-specific requirements for cellular transformation. Cancer Cell 2004, 6:171-183. 10.1016/j.ccr.2004.07.009, 15324700.
32. Herbert BS, Wright WE, Shay JW. p16(INK4a) inactivation is not required to immortalize human mammary epithelial cells. Oncogene 2002, 21:7897-7900. 10.1038/sj.onc.1205902, 12420227.
33. Soule HD, Maloney TM, Wolman SR, Peterson WD, Brenz R, McGrath CM, Russo J, Pauley RJ, Jones RF, Brooks SC. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 1990, 50:6075-6086.
34. Hayward SW, Wang Y, Cao M, Hom YK, Zhang B, Grossfeld GD, Sudilovsky D, Cunha GR. Malignant transformation in a nontumorigenic human prostatic epithelial cell line. Cancer Res 2001, 61:8135-8142.
35. Page DL, Dupont WD, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 1985, 55:2698-2708. 10.1002/1097-0142(19850601)55:11<2698::AID-CNCR2820551127>3.0.CO;2-A, 2986821.
36. Thaler S, Hahnel PS, Schad A, Dammann R, Schuler M. RASSF1A Mediates p21Cip1/Waf1-Dependent Cell Cycle Arrest and Senescence through Modulation of the Raf-MEK-ERK Pathway and Inhibition of Akt. Cancer Res 2009,
37. Shivakumar L, Minna J, Sakamaki T, Pestell R, White MA. The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol Cell Biol 2002, 22:4309-4318. 10.1128/MCB.22.12.4309-4318.2002, 133879, 12024041.
38. Liu L, Zhang J, Bates S, Li JJ, Peehl DM, Rhim JS, Pfeifer GP. A methylation profile of in vitro immortalized human cell lines. Int J Oncol 2005, 26:275-285.
39. Tommasi S, Dammann R, Zhang Z, Wang Y, Liu L, Tsark WM, Wilczynski SP, Li J, You M, Pfeifer GP. Tumor susceptibility of Rassf1a knockout mice. Cancer Res 2005, 65:92-98.
40. Lo PK, Mehrotra J, D'Costa A, Fackler MJ, Garrett-Mayer E, Argani P, Sukumar S. Epigenetic suppression of secreted frizzled related protein 1 (SFRP1) expression in human breast cancer. Cancer Biol Ther 2006, 5:281-286.
41. Rivenbark AG, Livasy CA, Boyd CE, Keppler D, Coleman WB. Methylation-dependent silencing of CST6 in primary human breast tumors and metastatic lesions. Exp Mol Pathol 2007, 83:188-197. 10.1016/j.yexmp.2007.03.008, 2693953, 17540367.
42. Gort EH, Suijkerbuijk KP, Roothaan SM, Raman V, Vooijs M, Wall E, van Diest PJ. Methylation of the TWIST1 promoter, TWIST1 mRNA levels, and immunohistochemical expression of TWIST1 in breast cancer. Cancer Epidemiol Biomarkers Prev 2008, 17:3325-3330. 10.1158/1055-9965.EPI-08-0472, 19064546.
43. Mehrotra J, Vali M, McVeigh M, Kominsky SL, Fackler MJ, Lahti-Domenici J, Polyak K, Sacchi N, Garrett-Mayer E, Argani P, Sukumar S. Very high frequency of hypermethylated genes in breast cancer metastasis to the bone, brain, and lung. Clin Cancer Res 2004, 10:3104-3109. 10.1158/1078-0432.CCR-03-0118, 15131050.
44. Hellman A, Chess A. Gene body-specific methylation on the active X chromosome. Science 2007, 315:1141-1143. 10.1126/science.1136352, 17322062.
45. Illingworth R, Kerr A, Desousa D, Jorgensen H, Ellis P, Stalker J, Jackson D, Clee C, Plumb R, Rogers J, Humphray S, Cox T, Langford C, Bird A. A novel CpG island set identifies tissue-specific methylation at developmental gene loci. PLoS Biol 2008, 6:e22. 10.1371/journal.pbio.0060022, 2214817, 18232738.